Articles
Rivaroxaban plus aspirin improves outcomes in stable cardiovascular disease (COMPASS)
Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with stable coronary or peripheral artery disease, according to late-breaking results from...
Articles
Enhancing process safety and efficiency in the pharmaceutical industry with check Weighing solutions
A look at how pharmaceutical manufacturers can benefit from the use of dynamic checkweighing technology to comply with international standards, increase process safety, productivity and process...
Articles
ViscoTec Pharma Dispenser VPHD on the test
With nearly 140 years of success, Henkel holds globally leading market positions both in the consumer and industrial sectors and is well known for brands...
Articles
Biofortuna reaches key milestones for ReadyPlex blood group
Biofortuna Ltd, a UK-based diagnostics company offering molecular diagnostic products and contract manufacturing services, has successfully achieved key milestones in the development of its new...
Research Insight
Boehringer Ingelheim and Harvard scientists establish a research alliance
Boehringer Ingelheim announced it has established a research collaboration with the Harvard Stem Cell Institute’s - Harvard Fibrosis Network to discover new ways of treating...
Research Insight
Mylan Launches First Generic of Nuvigil Tablets
Mylan N.V. announced the U.S. launch of Armodafinil Tablets, 50 mg, 150 mg, 250 mg, a generic version of Cephalon's Nuvigil®. Mylan received final approval...
Research Insight
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
Allergan plc announced that two pivotal trials of the Oculeve Intranasal Tear Neurostimulator, OCUN-009 and OCUN-010, each met their primary and secondary efficacy endpoints. With...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















